BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 9861328)

  • 1. Gonadotrophin and prolactin secretory dynamics in girls with normal puberty, idiopathic precocious puberty and precocious puberty due to hypothalamic hamartoma.
    Uriarte MM; Klein KO; Barnes KM; Pescovitz OH; Loriaux DL; Cutler GB
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):363-8. PubMed ID: 9861328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin secretory dynamics during puberty in normal girls and boys.
    Oerter KE; Uriarte MM; Rose SR; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1251-8. PubMed ID: 2121771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
    Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology of gonadotropin secretion in patients with idiopathic precocious puberty and follow up studies during and after therapy with medroxyprogesterone acetate (author's transl)].
    Aono T; Minagawa J; Terakawa N; Kurachi K; Matsumoto K
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):898-907. PubMed ID: 1241847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central precocious puberty: clinical and laboratory features.
    Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.
    Trueman JA; Tillmann V; Cusick CF; Foster P; Patel L; Hall CM; Price DA; Clayton PE
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):223-30. PubMed ID: 12153601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.
    Feuillan PP; Jones JV; Barnes KM; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4036-8. PubMed ID: 11095429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and clinical features of isosexual precocious puberty in Taiwanese girls: twenty-three years' experience in National Taiwan University Hospital.
    Lee CT; Tung YC; Tsai WY
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):947-53. PubMed ID: 20020583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of gonadotropin and estradiol secretion in exaggerated thelarche.
    Garibaldi LR; Aceto T; Weber C
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):345-50. PubMed ID: 8498153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of hypothalamic hamartoma causing central precocious puberty: long-term follow-up.
    Li CD; Luo SQ; Gong J; Ma ZY; Jia G; Zhang YQ; Li JF
    J Neurosurg Pediatr; 2013 Aug; 12(2):151-4. PubMed ID: 23746126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal ranges for immunochemiluminometric gonadotropin assays.
    Neely EK; Hintz RL; Wilson DM; Lee PA; Gautier T; Argente J; Stene M
    J Pediatr; 1995 Jul; 127(1):40-6. PubMed ID: 7608809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty.
    Lee HS; Yoon JS; Hwang JS
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):392-398. PubMed ID: 27215137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precocious puberty: clinical and endocrine profile and factors indicating neurogenic precocity in Indian children.
    Bajpai A; Sharma J; Kabra M; Kumar Gupta A; Menon PS
    J Pediatr Endocrinol Metab; 2002; 15(8):1173-81. PubMed ID: 12387516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of pulsatile gonadotrophin secretion and pituitary responsiveness in male puberty in man: a mixed longitudinal and cross-sectional study.
    Wu FC; Borrow SM; Nicol K; Elton R; Hunter WM
    J Endocrinol; 1989 Nov; 123(2):347-59. PubMed ID: 2514245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Girls with Premature Thelarche Younger than 3 Years of Age May Have Stimulated Luteinizing Hormone Greater than 10 IU/L.
    Seymen Karabulut G; Atar M; Çizmecioğlu Jones FM; Hatun Ş
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):377-382. PubMed ID: 32349465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.